Tirzepatide Calculator
A vial strength and a water volume give a concentration. A concentration and a syringe give units. Worked for the vial sizes tracked across vendors — not generic examples.
Last reviewed: September 20, 2026
Vial strength and water volume give a concentration; a dose then gives the unit mark it corresponds to.
For research purposes only. Always verify calculations independently before use.
On this page
What reconstitution is
Research-grade tirzepatide ships from vendors as a lyophilized (freeze-dried) powder sealed in a vial. Reconstitution is the act of dissolving that powder in a liquid — typically bacteriostatic water — which turns a fixed mass of peptide (the vial’s labeled mg content) into a solution with a defined concentration, measurable in volume with a syringe. The mass doesn’t change; only how that mass is distributed through a volume of liquid changes.
Tirzepatide itself is FDA-approved — as Mounjaro and Zepbound, both sold as pre-filled, ready-to-use solutions that the patient never reconstitutes. Neither label contains reconstitution instructions for that reason. The math below is generic pharmaceutical arithmetic (concentration = mass ÷ volume), applied to the vial sizes research-grade tirzepatide is actually sold in. For the compound’s mechanism (a dual GIP/GLP-1 receptor agonist) and trial evidence, see the tirzepatide profile.
What sizes does tirzepatide come in?
Read from live price data on September 20, 2026 (non-retired vendors only), 30 distinct vendors carry tirzepatide. The seven sizes below are each carried by 3 or more of those vendors. Coverage concentrates heavily at 10 mg, 30 mg, and 60 mg — each carried by 15 or more vendors — with 15 mg and 20 mg as a thinner middle tier.
| Vial size | Vendors tracking this size |
|---|---|
| 5 mg | 3 |
| 10 mg | 20 |
| 15 mg | 7 |
| 20 mg | 8 |
| 30 mg | 21 |
| 40 mg | 5 |
| 60 mg | 15 |
The arithmetic, worked
Concentration (mg/mL) equals the vial’s total mg divided by the water volume in mL. Micrograms per syringe unit, on a U-100 syringe (100 units = 1 mL), equals that concentration multiplied by 10. The table below reports both figures at two illustrative water volumes for each tracked size — as a statement of what each volume does to the concentration, not a recommendation of either:
| Vial size | At 1 mL water | At 2 mL water |
|---|---|---|
| 5 mg | 5 mg/mL — 50 mcg/unit | 2.5 mg/mL — 25 mcg/unit |
| 10 mg | 10 mg/mL — 100 mcg/unit | 5 mg/mL — 50 mcg/unit |
| 15 mg | 15 mg/mL — 150 mcg/unit | 7.5 mg/mL — 75 mcg/unit |
| 20 mg | 20 mg/mL — 200 mcg/unit | 10 mg/mL — 100 mcg/unit |
| 30 mg | 30 mg/mL — 300 mcg/unit | 15 mg/mL — 150 mcg/unit |
| 40 mg | 40 mg/mL — 400 mcg/unit | 20 mg/mL — 200 mcg/unit |
| 60 mg | 60 mg/mL — 600 mcg/unit | 30 mg/mL — 300 mcg/unit |
Doubling the water volume halves the concentration and halves the mcg delivered per unit drawn. The general dosage calculator runs this same arithmetic for any vial size and water volume, including ones outside the table above.
Units to draw, by vial size and dose
Every cell is the U-100 unit mark a given dose comes to, for a given vial strength, at 2 mL of bacteriostatic water. The rows are the vial sizes three or more tracked vendors carry; the columns are round dose values, chosen so the table reads cleanly across that range. They are not a schedule and nothing here suggests one — the label schedules for the branded tirzepatide products are set out in the Mounjaro and Zepbound dosing guides.
| Vial | 1 mg | 2 mg | 5 mg | 7.5 mg | 10 mg | 15 mg | 20 mg |
|---|---|---|---|---|---|---|---|
| 5 mg | 40.0 | 80.0 | 200.0 | 300.0 | 400.0 | 600.0 | 800.0 |
| 10 mg | 20.0 | 40.0 | 100.0 | 150.0 | 200.0 | 300.0 | 400.0 |
| 15 mg | 13.3 | 26.7 | 66.7 | 100.0 | 133.3 | 200.0 | 266.7 |
| 20 mg | 10.0 | 20.0 | 50.0 | 75.0 | 100.0 | 150.0 | 200.0 |
| 30 mg | 6.7 | 13.3 | 33.3 | 50.0 | 66.7 | 100.0 | 133.3 |
| 40 mg | 5.0 | 10.0 | 25.0 | 37.5 | 50.0 | 75.0 | 100.0 |
| 60 mg | 3.3 | 6.7 | 16.7 | 25.0 | 33.3 | 50.0 | 66.7 |
Figures over 100 are shown in amber: they exceed a 1 mL U-100 barrel at this water volume, so that combination does not fit one syringe. More water lowers the concentration and raises the unit count; less water does the reverse. The calculator above works any vial, volume and dose, in either direction.
What one vial comes to
The three sizes the most tracked vendors carry, worked at 2 mL. “Doses per vial” is the vial’s total divided by the dose — how many times that amount is present in the vial, before any loss in handling.
30 mg vial at 2 mL — 15.00 mg/mL
| Dose | Units to draw | Draw volume | Doses per vial |
|---|---|---|---|
| 1 mg | 6.7 | 0.07 mL | 30.0 |
| 2 mg | 13.3 | 0.13 mL | 15.0 |
| 5 mg | 33.3 | 0.33 mL | 6.0 |
| 7.5 mg | 50.0 | 0.50 mL | 4.0 |
| 10 mg | 66.7 | 0.67 mL | 3.0 |
| 15 mg | 100.0 | 1.00 mL | 2.0 |
| 20 mg | 133.3 | 1.33 mL | 1.5 |
10 mg vial at 2 mL — 5.00 mg/mL
| Dose | Units to draw | Draw volume | Doses per vial |
|---|---|---|---|
| 1 mg | 20.0 | 0.20 mL | 10.0 |
| 2 mg | 40.0 | 0.40 mL | 5.0 |
| 5 mg | 100.0 | 1.00 mL | 2.0 |
| 7.5 mg | 150.0 | 1.50 mL | 1.3 |
| 10 mg | 200.0 | 2.00 mL | 1.0 |
| 15 mg | 300.0 | 3.00 mL | 0.7 |
| 20 mg | 400.0 | 4.00 mL | 0.5 |
60 mg vial at 2 mL — 30.00 mg/mL
| Dose | Units to draw | Draw volume | Doses per vial |
|---|---|---|---|
| 1 mg | 3.3 | 0.03 mL | 60.0 |
| 2 mg | 6.7 | 0.07 mL | 30.0 |
| 5 mg | 16.7 | 0.17 mL | 12.0 |
| 7.5 mg | 25.0 | 0.25 mL | 8.0 |
| 10 mg | 33.3 | 0.33 mL | 6.0 |
| 15 mg | 50.0 | 0.50 mL | 4.0 |
| 20 mg | 66.7 | 0.67 mL | 3.0 |
What changes the answer
- Water volume. Concentration is inversely proportional to water volume. A larger water volume produces a lower concentration, meaning more units are needed to reach the same mg amount, which can exceed a syringe’s barrel capacity at low concentrations and high mg amounts — a real constraint at tirzepatide’s higher vial sizes (40 mg, 60 mg) more than at its smaller ones.
- Vial size. For a fixed water volume, concentration is directly proportional to vial size — a 30 mg vial reconstituted with 1 mL is three times the concentration of a 10 mg vial reconstituted the same way.
- Syringe calibration. Every figure above assumes a U-100 syringe (100 units = 1 mL), the standard for peptide research (see the syringes and injection guide). A different calibration would report a different units figure for the identical physical volume; it does not change the concentration or the mg delivered.
How long does reconstituted tirzepatide last?
Mounjaro and Zepbound’s labels state their pre-filled single-dose pens and vials are refrigerated at 2–8°C (36–46°F), and may be kept unrefrigerated at or below 30°C (86°F) for up to a total of 21 days before being discarded. That figure describes a manufactured, ready-to-use solution — not a research-grade lyophilized vial before or after a buyer reconstitutes it with bacteriostatic water.
Prof. Peptide has not identified a sourced figure for how long reconstituted research-grade tirzepatide remains stable, refrigerated or otherwise, from any manufacturer, regulator, or published study. This page does not state one as fact. A vendor’s own product page may state a shelf-life figure; that is the vendor’s claim, not an independently verified one, and is outside what this page reports.
FAQ
How do I reconstitute tirzepatide?
Does the water volume change how much tirzepatide is in the vial?
What syringe do the unit figures on this page assume?
Is this the same as how Mounjaro or Zepbound are dosed?
What if my vial's size isn't in the table below?
How much BAC water for a 5mg tirzepatide vial?
How much BAC water for a 10mg tirzepatide vial?
How much BAC water for a 15mg tirzepatide vial?
How much BAC water for a 20mg tirzepatide vial?
How much BAC water for a 30mg tirzepatide vial?
How much BAC water for a 40mg tirzepatide vial?
How much BAC water for a 50mg tirzepatide vial?
How much BAC water for a 60mg tirzepatide vial?
How much BAC water for a 100mg tirzepatide vial?
How much BAC water for a 120mg tirzepatide vial?
References
- Eli Lilly and Company. MOUNJARO (tirzepatide) injection — prescribing information, section 16 (How Supplied/Storage and Handling). DailyMed, setid d2d7da5d-ad07-4228-955f-cf7e355c8cc0, effective 2026-08-27. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- Eli Lilly and Company. ZEPBOUND (tirzepatide) injection — prescribing information, section 16 (How Supplied/Storage and Handling). DailyMed, setid 487cd7e7-434c-4925-99fa-aa80b1cc776b, effective 2026-08-28. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
We may earn commissions from peptide vendor affiliate links.
